{"id":3049,"date":"2020-10-30T23:25:28","date_gmt":"2020-10-30T23:25:28","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=3049"},"modified":"2020-10-30T23:25:54","modified_gmt":"2020-10-30T23:25:54","slug":"cuban-vaccine-soberana-02-to-start-phase-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cuban-vaccine-soberana-02-to-start-phase-clinical-trials\/","title":{"rendered":"Cuban Vaccine Soberana 02 To Start Phase Clinical Trials"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">Soberana 02 is the second Cuban COVID-19 vaccine candidate to begin clinical trials after being approved by Cuba&#8217;s\u00a0medical regulatory authorities.<\/h3>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"747\" height=\"479\" src=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?resize=747%2C479&#038;ssl=1\" alt=\"\" class=\"wp-image-3050\" srcset=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?w=800&amp;ssl=1 800w, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?resize=300%2C192&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?resize=768%2C492&amp;ssl=1 768w\" sizes=\"auto, (max-width: 747px) 100vw, 747px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The Cuban vaccine candidate against COVID-19, Soberana 02, will start Phase I clinical trials after receiving the approval of the Center for State Control of Drugs, Equipment, and Medical Devices (CECMED).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Finlay Institute of Vaccines announced the news in its official account on the social network Twitter.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In recent days, Doctor of Science Vicente V\u00e9rez Bencomo, General Director of the Finlay Institute, declared to Granma newspaper that this second candidate&#8217;s approval is similar to Soberana 01, and is a molecular or subunit product, would be imminent.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">V\u00e9rez Bencomo stated that during the clinical trials of this candidate, it is expected to demonstrate its safety and achieve a protective, powerful, and long-lasting immune response, just like Soberana 01, and prove which immunological properties are confirmed in the vaccinated subjects.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: <a href=\"https:\/\/www.telesurenglish.net\/news\/Cuban-Vaccine-Soberana-02-To-Start-Phase-I-Clinical-Trials-20201028-0014.html\" data-type=\"URL\" data-id=\"https:\/\/www.telesurenglish.net\/news\/Cuban-Vaccine-Soberana-02-To-Start-Phase-I-Clinical-Trials-20201028-0014.html\">Tele Sur<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Soberana 02 is the second Cuban COVID-19 vaccine candidate to begin clinical trials after being approved by Cuba&#8217;s\u00a0medical regulatory authorities. The Cuban vaccine candidate against<a class=\"moretag\" href=\"https:\/\/www.cubasupport.ie\/latest\/cuban-vaccine-soberana-02-to-start-phase-clinical-trials\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":3050,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[43],"tags":[],"class_list":["post-3049","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":2632,"url":"https:\/\/www.cubasupport.ie\/latest\/soberana-is-cubas-the-first-candidate-vaccine-against-covid-19-in-latin-america-and-the-caribbean\/","url_meta":{"origin":3049,"position":0},"title":"Soberana is Cuba\u2019s, the first candidate vaccine against COVID-19 in Latin America and the Caribbean","author":"Editorial Team","date":"August 27, 2020","format":false,"excerpt":"A vaccine that exemplifies the development of Cuban science; that places us on the level of economically advanced countries; that honors Comandante en Jefe Fidel Castro Ruz, the principal architect of the country\u2019s biotechnology sector. This is what Soberana is, the first Cuban candidate vaccine against COVID-19 authorized for testing\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2682,"url":"https:\/\/www.cubasupport.ie\/latest\/how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana\/","url_meta":{"origin":3049,"position":1},"title":"How did Cuba\u2019s COVID-19 candidate vaccine come to be named Soberana?","author":"Editorial Team","date":"September 3, 2020","format":false,"excerpt":"A name identifies, makes unique, and enamors\u2026 It is a calling card and can convey confidence and pride, which is exactly what occurred this month of August, when the people of Cuba heard the long-awaited news that our scientists had come up with an idea, an idea they turned into\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana.jpeg?fit=460%2C340&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":2708,"url":"https:\/\/www.cubasupport.ie\/latest\/us-newspaper-closely-follows-progress-of-cuban-vaccine-candidate\/","url_meta":{"origin":3049,"position":2},"title":"US newspaper closely follows progress of Cuban vaccine candidate","author":"Editorial Team","date":"September 9, 2020","format":false,"excerpt":"Cuban vaccine candidate Soberana 01 appears in the Covid-19 vaccine tracker on the US newspaper The New York Times website, Infomed reported today.According to Infomed (Cuba\u00b4s Health Network), the US newspaper registers 37 vaccines in human clinical trials and around 91 preclinical ones that are under active investigation in animals.\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3251,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-has-four-vaccine-candidates-against-covid-19-on-clinical-trials\/","url_meta":{"origin":3049,"position":3},"title":"Cuba has four vaccine candidates against Covid-19 on clinical trials","author":"Editorial Team","date":"November 27, 2020","format":false,"excerpt":"Cuba has registered four vaccine candidates against Covid-19 that are currently on clinical trials, after Mambisa and Abdala, developed by the Genetic Engineering and Biotechnology Center (CIGB), were authorized for this phase of the study.According to information released on social networks, the regulatory entity of Medicines, Equipment and Medical Devices\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3484,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-and-iran-alliance-on-covid-19-vaccine\/","url_meta":{"origin":3049,"position":4},"title":"Cuba and Iran alliance on COVID-19 vaccine","author":"Editorial Team","date":"January 12, 2021","format":false,"excerpt":"Cuba and\u00a0Iran\u00a0signed a bilateral agreement last Friday that establishes an alliance in the work for the development of a COVID-19 vaccine. The agreement was signed by the Finlay Vaccine Institute, belonging to the Cuban state group BioCubaFarma, and the Iranian Pasteur Institute \u201cto complement clinical evidence of the Soberana 02\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":4100,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-one-step-away-from-achieving-the-first-latin-american-vaccine-against-covid-19\/","url_meta":{"origin":3049,"position":5},"title":"Cuba, one step away from achieving the first Latin American vaccine against Covid-19","author":"Editorial Team","date":"April 22, 2021","format":false,"excerpt":"By\u00a0Mauricio Vicent They are called Soberana 02 and Abdala, and they are the two Cuban vaccine candidates against covid-19 that have gone the furthest in their development. Both are in phase 3 \u2014 the last before approval \u2014 of clinical trials. If everything goes as Cuban scientists hope, before the\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-Nb","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=3049"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3049\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/3050"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=3049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=3049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=3049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}